Status:
RECRUITING
A Registry Study on HIV-related Lymphoma
Lead Sponsor:
Rotkreuzklinikum München gGmbH
Conditions:
AIDS Related Lymphoma
HIV Related Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Detailed Description
To study characteristics, treatment approaches and outcome of HIV-infected patients with malignant lymphoma in the combination antiretroviral therapy (cART) era. HIV-infected persons diagnosed with no...
Eligibility Criteria
Inclusion
- Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
- HIV-infection at time of lymphoma diagnosis
- Lymphoma diagnosis since 01.01.2010
- Adult patients ≥ 18 years
- Written informed consent
Exclusion
- HIV-diagnosis \> 3 months after the diagnosis of malignant lymphoma
- Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)
Key Trial Info
Start Date :
August 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05231135
Start Date
August 25 2021
End Date
August 31 2029
Last Update
April 6 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Red Cross Hospital Munich
Munich, Select One Option, Germany, 80634
2
University Hospital Cologne
Cologne, Germany, 50937
3
Amsterdam University Medical Centers
Amsterdam, Netherlands
4
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain